These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19434367)

  • 21. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Actual therapeutic options in the treatment of generalized anxiety disorders].
    Delini-Stula A; Bondolfi G; Holsboer-Trachsler E
    Rev Med Suisse; 2010 Jun; 6(255):1370-4. PubMed ID: 20684132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
    Stevens JC; Pollack MH
    J Clin Psychiatry; 2005; 66 Suppl 2():21-7. PubMed ID: 15762816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepines, putative anxiolytics and animal models of anxiety.
    Green S
    Trends Neurosci; 1991 Mar; 14(3):101-4. PubMed ID: 1709533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical choice of a benzodiazepine].
    Villeneuve A
    Encephale; 1983; 9(4 Suppl 2):253B-259B. PubMed ID: 6144521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant plus benzodiazepine for major depression.
    Furukawa T; Streiner DL; Young LT
    Cochrane Database Syst Rev; 2000; (4):CD001026. PubMed ID: 11034696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute anxiolytic effects of quetiapine during virtual reality exposure--a double-blind placebo-controlled trial in patients with specific phobia.
    Diemer J; Domschke K; Mühlberger A; Winter B; Zavorotnyy M; Notzon S; Silling K; Arolt V; Zwanzger P
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1551-60. PubMed ID: 23375006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models of anxiety and the development of novel anxiolytic drugs.
    Sanger DJ; Perrault G; Morel E; Joly D; Zivkovic B
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):205-12. PubMed ID: 1678541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of anxiety disorders.
    McGowan OO
    Neurosci Lett; 2020 May; 726():134443. PubMed ID: 31442515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief review of published alprazolam clinical studies.
    Straw RN
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):57S-59S. PubMed ID: 2859879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of anxiety.
    Nash JR; Nutt DJ
    Handb Exp Pharmacol; 2005; (169):469-501. PubMed ID: 16594269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational use of anxiolytic drugs.
    Lader MH
    Ration Drug Ther; 1987 Sep; 21(9):1-5. PubMed ID: 2894038
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug mechanisms in anxiety.
    Bourin M; Hascoët M
    Curr Opin Investig Drugs; 2001 Feb; 2(2):259-65. PubMed ID: 11816841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
    Davies MA; Conley Y; Roth BL
    Biol Res Nurs; 2011 Jan; 13(1):55-60. PubMed ID: 20097665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug treatment of anxiety disorders].
    Corfdir C; Pelissolo A
    Rev Prat; 2019 Nov; 69(9):981-984. PubMed ID: 32237616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.